Cytovale logo

Cytovale

At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.

121 employees · est. 2013 · South San Francisco, United...

VS
Inflammatix, Inc. logo

Inflammatix, Inc.

We’re reimagining diagnostics by reading the immune system

96 employees · est. 2016 · Sunnyvale, United States

Cytovale is the older company (2013 vs 2016).

Side-by-Side Comparison

Cytovale Inflammatix, Inc.
Founded
2013 older 2016
Headquarters
South San Francisco, United States Sunnyvale, United States
Employees
121 96
Industry
AI, Health Care, Life Sciences Big Data, Biotechnology, Health Care
Funding Stage
Series C Grant
Total Funding
$128.59M $137.80M
Funding Rounds
9 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Medical Diagnostics, Cell Mechanics, Sepsis Diagnosis, Immune-mediated Diseases, Early Detection Technologies, Biomechanical Evaluation, FDA Cleared, Rapid Diagnostics, San Francisco-based Company, Immune Response, Critical Care, Sepsis Mortality Diagnostics, Point-of-care Testing, Immune System, Acute Infection, Sepsis, Immune Response Diagnostics, Bacterial Infection, Viral Infection, ICU Care, Emergency Department, Therapy Decisions, Clinical Innovation, Regulatory Approval
Website
cytovale.com inflammatix.com
Cytovale logo

About Cytovale

Cytovale: Cytovale, a medical diagnostics company founded in 2013, is focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test pioneers a new way of quickly and accurately analyzing white blood cells to stratify a pa...

Inflammatix, Inc. logo

About Inflammatix, Inc.

Inflammatix, Inc. is a U.S.-based startup that is revolutionizing diagnostics through its innovative approach of tapping into the immune system. Founded in 2016, the company's mission is reflected in its slogan "We're reimagining diagnostics by reading the immune system." Inflammatix is focused on d...

We will tell you when either one moves

BounceWatch watches Cytovale and Inflammatix, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cytovale and Inflammatix, Inc. — by email.

Frequently Asked Questions

Cytovale — At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases. . Inflammatix, Inc. — We’re reimagining diagnostics by reading the immune system. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cytovale has raised $128.59M while Inflammatix, Inc. has raised $137.80M.
Cytovale and Inflammatix, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cytovale with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cytovale on 12 Sep 2024, and Inflammatix, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy